Related Experiment Video
Updated: Jul 15, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Insights into Melanoma Clinical Practice: A Perspective for Future Research
Giang T Lam1, Carmela Martini1, Tiffany Brooks2,3
1Clinical and Health Sciences, University of South Australia, North Terrace, Adelaide, SA 5000, Australia.
Clinicians face significant challenges in melanoma diagnosis, often requiring multiple immunohistochemistry (IHC) markers for accuracy. Future research should focus on developing new biomarkers to improve clinical decision-making in melanoma assessment.
Area of Science:
- Dermatopathology
- Oncology
- Medical Diagnostics
Background:
- Early melanoma diagnosis is crucial for patient outcomes.
- Standardized histological assessment is necessary for accurate melanoma diagnosis.
- Understanding clinician challenges in melanoma assessment is vital for research direction.
Purpose of the Study:
- To identify challenges faced by clinicians in melanoma diagnosis.
- To gather perspectives on diagnostic needs and future research areas.
Main Methods:
- An online survey was distributed to national and international dermatologists, pathologists, general practitioners, and laboratory managers.
- The survey consisted of six questions, with data analyzed using descriptive statistics and qualitative responses.
- Data collected between April 2022 and February 2023 from 54 respondents.
Main Results:
- 96.4% of respondents reported monthly ambiguity in melanoma diagnosis.
- 82.1% routinely used immunohistochemistry (IHC) testing for diagnostic confirmation.
- Multiple IHC markers, particularly SOX10, were preferred over single markers; diagnostic/prognostic tests and therapeutics were key research areas.
Conclusions:
- Multiple IHC markers are essential for accurate melanoma assessment.
- There is an urgent need for novel biomarkers to aid clinical decision-making at critical intervention points in melanoma management.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis

